Supira Medical announced today that it completed an oversubscribed Series E financing round, bringing in $120 million. The clinical-stage Shifamed portfolio company also recently completed enrollment for its U.S. SUPPORT I Early Feasibility Study (EFS) evaluating its percutaneous ventricular assist device (pVAD) for treating high-risk percutaneous coronary intervention (HRPCI). New investors Novo Holdings and Qatar […]
Shifamed
Supira begins early feasability study for percutaneous ventricular assist device
Supira Medical announced today that it began patient enrollment in a U.S. early feasibility trial of its percutaneous ventricular assist device (pVAD). The Shifamed portfolio company plans to evaluate the pVAD in patients undergoing high-risk percutaneous coronary intervention (HRPCI). Los Gatos, California-based Supira’s study looks at the safety and feasibility of the low-profile, high-flow device. […]
FDA approves IDE for Akura Medical’s thrombectomy system
Akura Medical, a Shifamed portfolio company, announced today that the FDA granted its Katana system investigational device exemption (IDE). IDE means Akura can begin the QUADRA-PE study evaluating the thrombectomy system in patients with acute pulmonary embolism (PE). Dr. Sanjum Sethi (Columbia University Medical Center) and Dr. Ann Gage (Tristar Centennial Medical Center) serve as co-principal […]
Shifamed’s Tioga Cardiovascular has first human cases with mitral valve replacement
Tioga Cardiovascular, a Shifamed portfolio company, today announced the first-in-human implants for its Luna TMVR system. Luna, a 28 Fr. transcatheter mitral valve replacement (TMVR) system, features a unique valve and anchor design and utilizes nitinol. Los Gatos, California-based Tioga designed it to minimize patient exclusions and treat more patients with mitral regurgitation (MR). Dr. […]
Shifamed’s Adona Medical raises $33.5M
Shifamed portfolio company Adona Medical announced today that it raised $33.5 million in a Series C financing round to support its adjustable heart shunt technology. Cormorant Asset Management and TCP Health Ventures led the financing. Excelstar Ventures, the PA MedTech VC Fund II, Unorthodox Ventures, AMED Ventures and other new and existing investors participated. (Our sibling site […]
Shifamed’s Laza Medical closes $36M Series A to support cardiac imaging tech
Laza Medical, the latest Shifamed portfolio company, announced today that it closed a Series A financing worth $36 million. The latest positive news for a Shifamed company follows multiple milestones over the course of 2023. In June, Shifamed’s Adona Medical unveiled a next-generation heart failure management portfolio. In October, its Akura Medical unit raised $35 […]
Shifamed’s Akura Medical raises $35M for thrombectomy system
Akura Medical, a Shifamed portfolio company, today announced the closing of a $35 million Series B financing round. Los Gatos, California-based Akura develops a differentiated approach to address the challenges of venous thromboembolism (VTE). The company earmarked the funds for supporting its FDA 510(k) clearance submission for the Akura mechanical thrombectomy platform. Other uses include […]
Shifamed’s Adona Medical unveils next-gen heart failure management platform
Shifamed portfolio company Adona Medical today announced the introduction of its next-generation heart failure platform. Brian Fahey, Adona Medical co-founder and CEO, unveiled the developing interatrial shunt technology in a presentation at the CSI Frankfurt 2023 conference. The Adona heart failure management platform features an adjustable interatrial shunt with integrated bi-atrial pressure monitoring. Its shunt […]
Adona Medical raises $20.5M
Shifamed portfolio company Adona Medical filed an SEC Form D to confirm the sale of nearly $20.5 million in equity. Campbell, Calif.-based Adona Medical is offering more than $24.8 million in equity in a new notice that had its first sale on Aug. 20, 2020. Adona Medical does not intend for the offering to last […]
Atia Vision closes $20m Series D
Shifamed spinout and intraocular lens maker Atia Vision announced today that it closed the second tranche of a $20 million Series D financing. Campbell, Calif.-based Atia Vision said in a news release that the funding round that was led by Cormorant Asset Management with participation from The Capital Partnership, AMED Ventures and Shangbay Capital. The […]
Myra Medical raises $3m seed round, lures ex-MVRx chief Chang as new CEO
Newly formed Shifamed spinout Myra Medical said today that it closed a seed financing round worth $3.2 million and announced the appointment of Robert Chang as CEO. Campbell, Calif.-based Myra Medical was founded to produce surgical devices designed to enable maximum intraocular pressure reduction while reducing the risk of hypotony in patients with glaucoma. Proceeds […]
